Able Diagnostics, Inc. products

The 1st Point-of-Care (POC) Antibody Test for COVID-19 with Fingerstick Whole Blood Authorized by FDA!. Click the link to review FDA NEWS RELEASE on Sept 23, 2020 in details: "FDA Authorizes First Point-of-Care Antibody Test for COVID-19" about Assure COVID-19 IgG/IgM Rapid Test Device. This authorization means that Fingerstick Blood Samples can now be tested in POC settings like Doctor`s offices, Urgent Care Centers, Emergency Rooms and Hospitals, rather than having to be sent to a central lab for testing. You can find Assure COVID-19 IgM/IgG Rapid Test (as the third company listed) to review the performance data summarized by FDA on EUA Authorized Serology Test Performance, and you can also review NCI`s Frederick National Laboratory for Cancer Research Evaluation Report for details.